AKT activity in fibroblasts increased in a dose‐dependent manner with HCT116 and SW620 EVs but not DLD1 or SW480, therefore, appearing unrelated to EMT status of donor CRC cells (Figure S3C). The gene discussed is AKT1; the disease is colorectal carcinoma.